Deep Learning for Histopathological Classification and Prognostication of Gynaecologic Smooth Muscle Tumours

ConditionStump
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorInstitut Bergonié

About this trial

Smooth muscle tumors of the uterus that do not fit the diagnostic criteria of benignity (such as leiomyomas) or malignancy (such as leiomyosarcomas) are called STUMP (smooth muscle tumor of uncertain malignant potential). A potential solution to this problem could be the application of predictive models using artificial intelligence (AI) to aid in the histopathological classification and prognosis of gynecological smooth muscle tumors. Deep learning using convolutional neural networks represents a specific class of machine learning, in which predictive models are trained by considering small groups of pixels in digital images and iteratively identifying salient features. In this study, we aim to develop deep learning models capable of accurately subclassifying and predicting the prognosis of gynecological smooth muscle tumors, based on histopathological features of hematoxylin and eosin (H\&E) slides. The aim is to develop a diagnostic and prognostic algorithm to help pathologists better classify and diagnose uterine smooth muscle tumors and predict their clinical course.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with a diagnosis of uterine smooth muscle tumors (leiomyomas, smooth muscle tumors of uncertain malignancy and leiomyosarcomas), registered in the RRePS database and/or treated at Institut Bergonié or one of the participating centers.

Histopathological material available (kerosene blocks and/or slides).

The follow-up (outcome) is required for each LMS/ STUMP.

Disqualifiers

na

Trial population

\- Uterine smooth muscle tumors: leiomyomas, smooth muscle tumors of uncertain malignancy and leiomyossarcomas.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • No intervention

    Other intervention

    No intervention since this is an observational study

Treatment groups

392 Participants
are divided into 2 treatment groups
Group A: STUMP cohort1 intervention
Group B: Leiomyoma-leiomyosarcoma1 intervention

Trial outcomes

Primary outcomes

1

Develop deep learning models that can accurately subclassify gynaecologic smooth muscle tumours

This project aims to improve the diagnosis and prognosis of gynecologic smooth muscle tumors, including leiomyomas (LM), leiomyosarcomas (LMS), and smooth muscle tumors of uncertain malignant potential (STUMP). In detail, a workflow comprising 2 stages will be developed to automatically classify GSMT subtypes from whole-slide images and to predict progression-free survival for patients in the LMS and STUMP groups, thereby providing clinicians with a more effective tool to improve workflow quality.

Time frame
throughout the conduct of the study - an expected average of 6 months after data collection

Secondary outcomes

1

Develop a prognostic tool for STUMP

Develop a model to predict progression-free survival for STUMP group based on the features extracted from Whole Slide Images.

Time frame
6 months after receiving the data.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.